2119 Capecitabine and bevacizumab (CB) maintenance treatment in metastatic colorectal cancer (mCRC): A cost-effectiveness analysis by Franken, M, Van Rooijen, E, Van Tinteren, H, May, A, Mol, L, Tije, A. Ten, Creemers, G.J, Velden, A. Van der, Van derTorren, A, Groot, C. Uyl-de, Punt, C, Koopman, M, Van Oijen, M

Get full text